Third Peer-Reviewed Study Shows Powerful Benefits of My Integrative Prostate Formula
Dietary supplements are used as alternative or adjuvant therapies. However, rigorous scientific verification of their biological activity in vitro and in vivo is necessary for the acceptance of dietary supplements in conventional cancer treatment and prevention.
Prostate cancer remains a leading cause of cancer-related death for men in developed countries. One in six men will fight prostate cancer in their lifetime, and in many cases this disease is aggressive and difficult to treat using conventional therapies alone. Researchers are constantly seeking safe and effective methods to halt or slow prostate cancer progression, and as a product formulator and prostate cancer expert, I have devoted much of my career to this area of research. By using some of the most advanced findings in this field, I’ve developed an all-natural integrative prostate formula that continues to be studied at major research institutes with positive results.
Most recently, an
important in vivo study was published in an international medical
journal, demonstrating the effectiveness and safety of this formula against
aggressive prostate cancer in a human xenograft model (explained below). This
is now the third published study from a major university to show significant
results of my multi-nutrient
prostate formula against the invasive behavior of aggressive prostate cancer
cells, tumor growth and metastasis. The formula was
previously studied at research laboratories at Columbia University New York, NY
and at the Cancer Research Laboratory, Methodist Research Institute, Indiana
University Health, Indianapolis, IN, using in vitro methods (cell
culture studies) and gene expression analysis. These prior studies also showed
significant results in this formula’s ability to inhibit prostate cancer growth
and proliferation through multiple mechanisms of action.
Suppresses Aggressive Tumor Growth without Side Effects
Results of the study show
that the oral administration of this formula produced a statistically
significant 27 percent suppression of tumor growth, compared to controls. The
study was performed using a xenograft tumor model of human prostate cancer in
mice. A xenograft model is made by grafting or transplanting tissue or organs
from an individual of one species onto an organism of another species, genus,
or family. In this case, highly aggressive human prostate cancer cells (PC-3)
were grafted onto mice.
Inhibits Genes Involved in Tumor Growth and Metastasis
In addition to a
significant reduction in tumor volume, results of this study showed that the
formula also inhibited the expression of several genes involved in cancer
proliferation and metastasis. Three prostate cancer-related genes (IGF2, NRNF2 and PLAU/uPA) that were suppressed
by this formula not only control aggressive prostate tumor growth, but also
relate to the metastatic potential. The formula also significantly increased
the expression of a gene that fights against prostate cancer, CDKN1A, which
works by specifically inhibitingother cancer-promoting cellular mechanisms.
By suppressing specific
genes related to aggressive prostate cancer growth and proliferation, and
increasing the expression of cancer-fighting genes, this integrative formula
demonstrated multiple anti-cancer mechanisms and genetic targets.This in
vivo study confirms previously published in vitro data which
also shows the ability of this formula to decrease the expression of PLAU/uPA
genes in aggressive, hormone-independent prostate cancer cells.
Prostate Cancer from Multiple Angles
For more information about this study, visit http://www.spandidos-publications.com/10.3892/ijo.2012.1344 For further details about my formula, visit www.prostatehealthsolutions.org
Source: Free Articles from ArticlesFactory.com
ABOUT THE AUTHOR
Dr. Isaac Eliaz, M.D., MS., L.Ac., has been a pioneer in integrative medicine since the early 1980s. He is a respected researcher, innovative product formulator, clinical practitioner, author and lecturer. Dr. Eliaz is widely regarded as the leading expert in the field of Modified Citrus Pectin research and has been using Modified Citrus Pectin in his clinical practice for over 15 years to treat a variety of conditions.